The research interests of our Group have evolved over the years, while always centred on trying to decipher the molecular mechanisms that drive cancer and other age-related diseases. We initially focused on studying replication stress (RS), a form of DNA damage sensed and controlled by the ATR kinase, which we revealed plays a central role in cancer and ageing. Amongst other achievements, we developed novel ATR inhibitors and contributed to elucidating their mechanism of action and the molecular determinants of resistance to these drugs. From this early work, we developed a growing interest in the molecular mechanisms that drive resistance to cancer therapies, a major challenge in oncology. Beyond basic science, we use this knowledge to develop novel treatments targeting therapy-resistant cancer cells.
Investigadores Científicos
- Vanesa Lafarga
- Matilde Murga
Becarios Post-doctorales
- Ivó Hernández
Becarios Pre-Doctorales
- Julia Carballeira
- Amin El Manchoud
- Gema López
- Mario López
- Ana Martínez
- Jorge Mota
- Belén Navarro
- Anabel Sáez
Técnicos de Laboratorio
- Marta Elena Antón
- Alicia González
- Sara Rodrigo
Publicaciones recientes
- (2024). Nucleolar stress caused by arginine-rich peptides triggers a ribosomopathy and accelerates aging in mice. Mol Cell 84, 1527-1540. Publicación CNIO.
- (2024). Discovery of a novel inhibitor of macropinocytosis with antiviral activity. Mol Ther 32, 3012-3024. Publicación CNIO.
- (2024). The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ. EBioMedicine 103, 105124. Publicación CNIO.
- (2024). Cyclophilin D plays a critical role in the survival of senescent cells. EMBO J 43, 5972-6000. Publicación CNIO.
- (2024). SETD8 inhibition targets cancer cells with increased rates of ribosome biogenesis. Cell Death Dis 15, 694. Publicación CNIO.
Open Access - (2024). GRK2-mediated AKT activation controls cell cycle progression and G2 checkpoint in a p53-dependent manner. Cell Death Dis 10, 385. Publicación CNIO.
- (2023). Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET. Cell Death Differ 30, 1666-1678. Publicación CNIO.
Open Access - (2023). Decoding protein methylation function with thermal stability analysis.. Nat Commun 14, 3016. Publicación CNIO.
Open Access - (2023). A Multiparametric and High-Throughput Platform for Host-Virus Binding Screens. Nano Lett 23, 3701-3707. Publicación CNIO.
- (2023). PD-L1ATTAC mice reveal the potential of depleting PD-L1 expressing cells in cancer therapy. Aging (Albany NY) 15, 1791-1807. Publicación CNIO.
- (2023). A chemical screen underscores the essential role of STAT1-dependent IFN? signaling to regulate HLA-I expression in cancer cells. MicroPubl Biol (in press). Publicación CNIO.
- (2022). Distinct roles for PARP-1 and PARP-2 in c-Myc-driven B-cell lymphoma in mice.. Blood 139, 228-239. Publicación CNIO.
Open Access - (2022). A bispecific monomeric nanobody induces spike trimer dimers and neutralizes SARS-CoV-2 in vivo. Nat Commun 13, 155. Publicación CNIO.
Open Access - (2022). Targeting the nucleolus as a therapeutic strategy in human disease. Trends Biochem Sci (in press). Publicación CNIO.
- (2022). Activation of the integrated stress response is a vulnerability for multidrug-resistant FBXW7-deficient cells. EMBO Mol Med 0, e15855. Publicación CNIO.
Open Access - (2022). Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells. Mol Oncol 16, 148-165. Publicación CNIO.
Open Access - (2022). Emerging concepts in drug discovery for cancer therapy. Mol Oncol 16, 3757-3760. Publicación CNIO.
- (2022). Alkylating Agent-Induced Toxicity and Melatonin-Based Therapies. Front Pharmacol 13, 873197. Publicación CNIO.
- (2022). An in silico analysis identifies drugs potentially modulating the cytokine storm triggered by SARS-CoV-2 infection.. Sci Rep 12, 1626. Publicación CNIO.
Open Access - (2022). New regulators of the tetracycline-inducible gene expression system identified by chemical and genetic screens. FEBS Open Bio 12, 1896-1908. Publicación CNIO.
- (2021). USP7 limits CDK1 activity throughout the cell cycle. EMBO J 40, e99692. Publicación CNIO.
- (2021). Widespread displacement of DNA- and RNA-binding factors underlies toxicity of arginine-rich cell-penetrating peptides. EMBO J 40, e99692. Publicación CNIO.
Open Access - (2021). USP7 and VCP FAF1 define the SUMO/Ubiquitin landscape at the DNA replication fork. Cell Reports 37, 109819. Publicación CNIO.
- (2021). A chemical screen for modulators of mRNA translation identifies a distinct mechanism of toxicity for sphingosine kinase inhibitors. PLoS Biol 19, e3001263. Publicación CNIO.
Open Access - (2021). Coordinating DNA Replication and Mitosis through Ubiquitin/SUMO and CDK1.. Int J Mol Sci 22, 8796. Publicación CNIO.

